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Reply to Veromann
To the Editor:
We thank Dr. Siiri Veromann (Veromann 2002 [in this
issue]) for the interest shown in our article (Berry et al.
2001). Dr. Veromann has highlighted the fact that it is
difficult to explain why a mutation in CRYAB should
give rise to a discrete opacity at the posterior pole of
the lens, since a-crystallin continues to be synthesized
throughout life. Dr. Veromann suggests that the poste-
rior polar phenotype may occur secondary to an effect
on the regression of the primary vitreous.
The mechanisms by which precise genetic mutations
give rise to a specific lens phenotype are ill understood.
We know that mutations in different genes may give rise
to an identical lens phenotype, and we also know that
different mutations within the same gene may give rise
to very different patterns of lens opacification. Posterior
polar cataract is itself genetically heterogeneous (Rich-
ards et al. 1984; Ionides et al. 1997; Yamada et al. 2000).
Such genetic and allelic heterogeneity is common in other
inherited eye disorders, particularly in retinal dystro-
phies (Briggs et al. 2001; Sohocki et al. 2001). It remains
a challenge to identify the mechanism by which specific
mutations give rise to regional opacification within the
lens.
In our article, we suggested that the CRYAB mutation
could give rise to posterior polar cataract by two possible
mechanisms: either by impaired chaperone-like function
or by increased tendency of the mutant polypeptides to
aggregate as a direct effect of abnormal a-crystallin struc-
ture. Studies of the temporal and spatial distribution of
the aA- and aB-crystallin in the human lens suggest that
they are expressed ubiquitously, but their expression var-
ies at different time points during human lens develop-
ment. For instance, aB-crystallin is expressed in the lens
placode at Carnegie stage 13, but by stage 15 the lens
vesicle is intensely positive for both aA- and aB-crystallin
(Oguni et al. 1994). The effects of the mutant protein
could be manifested early in human lens development,
but, of course, aB-crystallin is also widely expressed in
many other cell types, including muscle, epithelial, and
endothelial cells, although the lens is the tissue that ex-
presses the highest physiological concentrations of these
proteins. It is conceivable, therefore, that the reported
mutation in CRYAB could have produced other clinical
symptoms, and we were aware of this possibility. Indeed,
cardiac muscle expresses high levels of aB-crystallin (Kato
et al. 1991), but the family history and clinical analysis
failed to identify any cardiac problems.We suggest, there-
fore, that the effects of the reported mutation are most
likely restricted to the lens.
Impaired chaperone function and/or the increased ten-
dency of the mutant aB-crystallin polypeptide to aggre-
gate may affect the internal structure of lens fibers so
that opacification occurs. The subcapsular posterior re-
gion of the lens is the one where a-crystallin polypeptides
are most highly phosphorylated, at least in the bovine
lens (Chiesa et al. 1989). It is also a lens region where
there are functionally important cytoskeletal elements
that utilize aB-crystallin to function properly (Quinlan
and Prescott, in press). Phosphorylation modulates the
oligomerization status and function of small heat-shock
proteins and their interaction with the cytoskeleton, and
so it is possible to rationalize a localized cataract at the
lens posterior as the characteristic phenotypic manifes-
tation of this CRYAB mutation.
Dr. Veromann suggests another mechanism to account
for the position of the lens opacity. The hypothesis states
that the mutation impairs regression of the primary vit-
reous and that this may result in posterior polar cataract.
Lack of regression of the primary vitreous (or persistent
hyperplastic primary vitreous [PHPV]) is associated with
posterior polar cataract in humans, but the disorder is
usually unilateral and associated with other developmen-
tal abnormalities of the eye. A family with autosomal
recessive inherited nonsyndromic bilateral PHPV has
shown linkage to a 13-cM region on chromosome 10
(Khaliq et al. 2001). However, in this family, posterior
polar cataract was not a consistent feature. The associ-
ation between PHPV and posterior polar cataract has
been reported in mice (Colitz et al. 2000), but, again,
there are other developmental abnormalities, including
persistent tunica vasculosa lentis, detached retina, and an-
terior segment abnormalities.We have been unable to find
any literature relating to a role for aB-crystallin in the
regression of the primary vitreous, but, given the wide-
spread expression aB-crystallin transcripts in the devel-
oping eye, it remains a possibility that it may influence
regression of the primary vitreous. However, given the
current state of knowledge of its function, it is difficult
to identify a plausible biological mechanism by which a
mutation in aB-crystallin would result in failure of re-
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gression of the hyaloid system. Furthermore, in the family
in our study, all affected members were examined care-
fully after pupil dilatation, and none showed any evidence
of persistence of the hyaloid system.
Our knowledge of the relationship between genotype
and phenotype in different forms of inherited cataract
is at an early stage. In the family in our study, we can
only speculate how mutations in aB-crystallin give such
a localized opacity. Although Dr. Veromann has sug-
gested another possible mechanism, the evidence for this
is weak at present.
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